LINDSEY TANNER, AP Medical Writer CHICAGO (AP) — For nearly a century, insulin has been a life-saving diabetes treatment. Now scientists are testing a tantalizing question: What if pills containing the same medicine patients inject every day could also prevent the disease? Thirteen-year-old Hayden Murphy Read More
(Medical News Today) – In a new study, researchers from Weill Cornell Medical College in New York City, NY, found that the order in which different types of food are consumed has a significant impact on post-meal glucose and insulin levels in obese people. Writing Read More
(Daily Mail) – Bacteria responsible for common skin infections, food poisoning and MRSA could also trigger one of the most prevalent diseases of our time – type 2 diabetes. Researchers in the US discovered exposure to Staphylococcus aureus bacteria causes hallmark symptoms of the disease Read More
(BBC) – Scientists are hopeful that “smart” insulins which are undergoing trials could revolutionise the way diabetes is managed. Instead of repeated blood tests and injections throughout the day to keep blood sugar in check, a single dose of smart insulin would keep circulating in Read More
(CNBC) – Sanofi launched an inhalable insulin in the United States on Tuesday in a potential boost for its flagging diabetes drug sales and for patient quality of life. Developed by Mannkind, Afrezza will be the only inhalable insulin on the U.S. market, where Sanofi competes with Eli Read More
NEW HAVEN (New York Times) — One of my elderly patients has Type 2 diabetes and heart disease. He takes a number of medications, including insulin to control his blood sugar levels. A few years ago, he was driving when his blood sugar suddenly dropped. Read More
Special to the NNPA from The Dallas Examiner The battle of the bulge is a lifelong challenge for many women. This is largely because our bodies are designed to store fat more easily than men’s bodies to protect a potential fetus during the childbearing years. Read More
Jan 30 (Reuters) – Oramed, an Israeli developer of oral drug delivery systems, said on Thursday a mid-stage trial for its oral insulin capsule for the treatment of type 2 diabetes met all primary and secondary endpoints. During the Phase 2a trial, conducted under a Read More
[Business Week] The long promise of insulin that diabetics can inhale appears to be moving closer to the market. An inhalable insulin powder called Afrezza showed positive results for controlling diabetes in a late-stage clinical trial, the drug’s maker, MannKind (MNKD), reported today. Pharmaceutical companies have been Read More
©2018 National Newspaper Publishers Association. All rights reserved.